Profile data is unavailable for this security.
About the company
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. It is also focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. It has several ongoing trials in the areas of heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.
- Revenue in USD (TTM)163.42k
- Net income in USD280.64k
- Incorporated1971
- Employees37.00
- LocationDaxor CorpSUITE 7120, 350 FIFTH AVENUENEW YORK 10118United StatesUSA
- Phone+1 (212) 244-0555
- Fax+1 (212) 244-0806
- Websitehttps://www.daxor.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nova Vision Acquisition Corp | 0.00 | 82.84k | 39.95m | -- | 426.35 | 2.69 | 482.28 | -- | 0.0282 | 0.0282 | 0.00 | 4.47 | 0.00 | -- | -- | -- | 0.4387 | -- | 0.4897 | -- | -- | -- | -- | -- | -- | -- | 0.1431 | -- | -- | -- | 293.75 | -- | -- | -- |
| Aimfinity Investment Corp I | 0.00 | 1.67m | 40.45m | -- | 50.93 | 1.83 | -- | -- | 0.2203 | 0.2203 | 0.00 | 6.14 | 0.00 | -- | -- | -- | 2.61 | -- | 2.65 | -- | -- | -- | -- | -- | -- | -- | 0.0383 | -- | -- | -- | 644.00 | -- | -- | -- |
| Cetus Capital Acquisition Corp | 0.00 | 373.26k | 40.67m | 0.00 | 182.93 | 2.22 | 151.39 | -- | 0.0579 | 0.0579 | 0.00 | 4.77 | 0.00 | -- | -- | -- | 0.9222 | -- | 0.9464 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 1,021.42 | -- | -- | -- |
| AIB Acquisition Corp | 0.00 | -1.12m | 41.65m | -- | -- | 7.17 | -- | -- | -0.3106 | -0.3106 | 0.00 | 1.61 | 0.00 | -- | -- | -- | -9.85 | -- | -14.11 | -- | -- | -- | -- | -- | -- | -- | 0.1654 | -- | -- | -- | -224.63 | -- | -- | -- |
| Network-1 Technologies Inc | 2.06m | -1.75m | 41.91m | 2.00 | -- | 0.8705 | 100.75 | 20.31 | -0.0739 | -0.0739 | 0.0872 | 2.06 | 0.0393 | -- | -- | 1,032,000.00 | 0.3867 | 4.57 | 0.3933 | 4.75 | 64.97 | 62.89 | 9.84 | 31.08 | -- | -- | 0.00 | 173.75 | -- | -34.82 | 37.36 | -- | -- | 0.00 |
| DMY Squared Technology Group Inc | 0.00 | 1.60m | 41.93m | -- | 58.64 | 2.17 | -- | -- | 0.1825 | 0.1825 | 0.00 | 4.92 | 0.00 | -- | -- | -- | 3.49 | -- | 3.64 | -- | -- | -- | -- | -- | -- | -- | 0.0558 | -- | -- | -- | 196.18 | -- | -- | -- |
| Daxor Corp | 163.42k | 280.64k | 41.98m | 37.00 | -- | 1.24 | -- | 256.89 | -0.0362 | -0.0362 | 0.034 | 7.08 | 0.005 | -- | 5.13 | -- | 0.8618 | 7.13 | 0.8912 | 7.84 | -395.33 | -199.87 | 171.73 | 607.55 | -- | -- | 0.0217 | -- | -29.45 | -17.59 | -94.58 | -- | -- | -- |
| Herzfeld Caribbean Basin Fund Inc | 739.13k | 7.96m | 42.29m | -- | 2.83 | 0.7227 | -- | 57.21 | 0.889 | 0.889 | 0.0621 | 3.48 | 0.0158 | -- | -- | -- | 17.02 | 3.34 | 18.40 | 3.35 | 15.90 | -17.12 | 1,076.85 | 214.03 | -- | -- | 0.00 | 357.28 | 37.20 | -2.05 | 205.22 | -- | -- | 50.06 |
| Western Acquisition Ventures Corp | 0.00 | -1.03m | 42.30m | -- | -- | 402.31 | -- | -- | -0.2595 | -0.2595 | 0.00 | 0.0298 | 0.00 | -- | -- | -- | -1.70 | -- | -1.77 | -- | -- | -- | -- | -- | -- | -- | 0.6581 | -- | -- | -- | -47.60 | -- | -- | -- |
| Denali Capital Acquisition Corp | 0.00 | 1.91m | 43.09m | -- | 28.63 | 1.01 | 22.61 | -- | 0.2117 | 0.2117 | 0.00 | 5.97 | 0.00 | -- | -- | -- | 2.76 | -- | 2.95 | -- | -- | -- | -- | -- | -- | -- | 0.0479 | -- | -- | -- | 250.82 | -- | -- | -- |
| Yotta Acquisition Corp | 0.00 | 1.43m | 43.35m | 2.00 | 50.02 | 2,569.88 | -- | -- | 0.2197 | 0.2197 | 0.00 | 0.0043 | 0.00 | -- | -- | 0.00 | 2.28 | -- | 2.38 | -- | -- | -- | -- | -- | -- | -- | 0.9899 | -- | -- | -- | 884.52 | -- | -- | -- |
| Bellevue Life Sciences Acquisition Corp | 0.00 | 233.04k | 43.36m | -- | 549.13 | 1.86 | -- | -- | 0.0195 | 0.0195 | 0.00 | 5.77 | 0.00 | -- | -- | -- | 0.4302 | -- | 0.4431 | -- | -- | -- | -- | -- | -- | -- | 0.0041 | -- | -- | -- | 1,240.94 | -- | -- | -- |
| Rand Capital Corp | 7.55m | 5.76m | 43.85m | 0.00 | 7.62 | 0.7122 | -- | 5.81 | 2.23 | 2.23 | 2.93 | 23.85 | 0.0975 | -- | 27.11 | -- | 7.43 | 6.30 | 7.72 | 6.58 | 68.35 | 73.60 | 76.20 | 86.48 | -- | -- | 0.2377 | -- | 27.28 | 28.35 | 840.11 | -- | -- | -- |
| PMV Consumer Acquisition Corp | 0.00 | -86.93k | 43.88m | 0.00 | -- | -- | -- | -- | -0.8691 | -0.8691 | 0.00 | 5.44 | 0.00 | -- | -- | -- | -6.98 | -- | -13.11 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -101.25 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Daxor Corp's reporting currency: US Dollar USD
1.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 47.33k | 1.00% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 15.32k | 0.32% |
| Keyes, Stange & Wooten Wealth Management LLCas of 31 Mar 2024 | 10.84k | 0.23% |
| UBS Securities LLCas of 31 Mar 2024 | 1.16k | 0.02% |
| Princeton Global Asset Management LLCas of 31 Mar 2024 | 500.00 | 0.01% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 175.00 | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 5.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
